According to Tina Martinez, vice president and head of global products and solutions at Cencora, the wholesaler occupies a distinctive position within the global healthcare ecosystem, operating at the center of the pharmaceutical supply chain with a scale that extends well beyond the United States. As a global organization, the company is able to leverage…
Shots: The Chinese NMPA has accepted NDA & granted priority review to fanregratinib (HMPL-453) for the treatment of adults with advanced, metastatic, or unresectable ICC with FGFR 2 fusion/rearrangement who have previously received systemic therapy NDA was supported by the P-II trial in China, which met its 1EP of improved ORR, with 2EPs findings, incl….
Expansion increases tablet and capsule production capacity from December 22, 2025 Share Corona Remedies has announced the commencement of capacity expansion for the commercial production of tablets and capsules at its Bhayla manufacturing facility, effective December 22, 2025. The expansion is intended to address market demand and increase in-house production capacity….
While AstraZeneca has announced that it will participate in the 2026 JP Morgan Healthcare Conference, it hasn’t yet revealed details about its presentation. At the 2025 conference, the company detailed the company’s performance during the first three quarters of 2024. According to the CFO, this success due to efforts to expand its clinical pipeline. Later…
Shots: EirGenix has entered into a strategic collaboration and non-exclusive licensing agreement with Transcenta for its Highly Intensified Continuous Bioprocessing (HiCB) platform Under the agreement, Transcenta will grant EirGenix a non-exclusive license to its HiCB platform, incl. continuous perfusion & integrated hybrid continuous purification process technologies, as well as documentation, know-how & regulatory support to…
Newly improved formulations of best-selling drugs can help to stave off the sales losses associated with the patent cliff to some degree. Image credit: Bahtiar Maulanaa via ShutterStock.com. As the looming patent cliff approaches, some major blockbuster drugs are set to lose their exclusivity, with pharma companies making moves to try and reduce the impact….
Intas partners IntegriMedical for needle-free injections in IVF and gynaecology – Express Pharma Home Latest Updates Intas partners IntegriMedical for needle-free injections in IVF and gynaecology Source link
In many ways, it’s been a banner year for chronic disease. America’s enduring ailments became a central theme of the Trump administration, with health secretary Robert F. Kennedy Jr. wielding his influence over the president. Trump created a commission focused on childhood chronic illnesses, which issued two reports on the matter. Statehouses across the country…
MSI-H/dMMR colon cancer comprises 15% of resectable cases and responds poorly to chemotherapy. Credit: NMK-Studio/Shutterstock.com. Innovent Biologics has received China’s National Medical Products Administration (NMPA) approval for the New Drug Application (NDA) for Tabosun (ipilimumab N01 injection), a CTLA-4 monoclonal antibody for colon cancer. The approval covers its use in combination with sintilimab as a…
Pharma Outlook 2026: India’s leap from ‘World’s Pharmacy’ to ‘World’s Innovation Partner’ – Express Pharma Home Latest Updates Pharma Outlook 2026: India’s leap from ‘World’s Pharmacy’ to ‘World’s Innovation Partner’ Source link